AM-001

N/A

Report date: 2023/04/24 20:00:24

Base Information

Drug NameAM-001
Drug Alias NamePotassium dobesilate topical - DermAct Pharmaceuticalpotassium dobesilateAM-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibroblast growth factor receptors antagonists
TargetsFibroblast growth factor receptors
Therapy Area/IndicationsPlaque psoriasisSkin Diseases, PapulosquamousSkin Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesDominican Republic
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEverett Labs
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmderma
Active IndicationsN/A
Inactive IndicationsPlaque psoriasisSkin Diseases, PapulosquamousSkin Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A